In a bid to to collaborate with industry partners to develop digital health tools for diabetes management, Joslin Diabetes Center has added a technology translation division, according to a company statement. It is part of a broader trend of companies using digital health to bring down the healthcare costs associated with treating and managing chronic conditions such as diabetes.
One of the priorities for the new division is to develop clinical decision support tools for glucose and insulin management along with other digital health solutions. Medical device company Dexcom, which develops continuous glucose monitors, is the first industry partner for the institute. Some of the other work ahead of the technology translation division includes:
- Collaborate with medical device and technology companies to use digital health tools control costs in healthcare;
- Create individualized, confidential collaborations with industry partners providing new solutions that advances the monitoring and treatment of diabetes with new technologies; and
- Pioneer innovative education and training programs that optimize decision-making processes and the adoption of best-in-class technologies for healthcare professionals and patients.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Earlier this year, Joslin launched a collaboration with Glooko — a mobile health company to treat diabetes — to roll out a diabetes management platform that uses patients’ shared diabetes management data for remote monitoring, coaching and to guide diabetes patients between office visits.
[Photo credit: Medical doctor hand from Big Stock Photos]
